At a glance
- Originator Malesci
- Class Anti-inflammatories; Antiallergics; Antiasthmatics; Bronchodilators; Small molecules
- Mechanism of Action Histamine H1 receptor antagonists; Muscarinic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Allergic asthma; Allergic rhinitis
Most Recent Events
- 12 Apr 2000 Discontinued-Preclinical for Allergic asthma in Italy (Inhalation)
- 12 Apr 2000 Discontinued-Preclinical for Allergic rhinitis in Italy (Intranasal)
- 10 May 1999 New profile